Reaction
Benign Neoplasm Of Thyroid Gland reporting signals
As of the last recalculation, Benign Neoplasm Of Thyroid Gland appears in 724 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is BARICITINIB (PRR 15.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Baricitinib | 5 | 15.0 | 15.0 |
| Liraglutide | 24 | 14.4 | 14.4 |
| Exenatide | 13 | 7.2 | 7.2 |
| Dulaglutide | 15 | 4.9 | 4.9 |